Inhibition of Inducible Nitric Oxide Synthase (iNOS) by Andrographolide and In Vitro Evaluation of Its Antiproliferative and Proapoptotic Effects on Cervical Cancer

Figure 6

(a) 2D structure of andrographolide; (b) analysis of Ligand Root Mean Fluctuation (L-RMSF) of the andrographolide ligand. (c) SSE distributions by residue index throughout the protein structure iNOS. (d) SSE distribution by residue index of iNOS-andrographolide complex, summary of SSE composition for each trajectory frame throughout the simulation, (e) SSE composition for only protein, and (f) SSE composition for (protein complex).

(a)

(b)

(c)

(d)

(e)

(f)